The News Review:
- Worlds Top Diabetes Scientists to Convene in Seattle to Launch…
- Breaking new ground in biotechnology
- Science world riven by man on a mission to make research pay
- Controlling AIDS lies in distant hope of vaccine
Worlds Top Diabetes Scientists to Convene in Seattle to Launch…
DentalPlans.com – Aug 21, 2007
com) – SEATTLE ? More than 100 of the world’s foremost diabetes experts from more than 20 countries and six continents will meet in Seattle this ctober to develop an ambitious clinical research agenda to address the prevention treatment and cure of diabetes. To spearhead the effort the scientists will launch the first-ever global alliance focusing on the clinical research of diabetes in indigenous disproportionately-impacted and underserved populations throughout the world. ?Diabetes is a worldwide epidemic growing at alarming rates? said Dr. Paul Robertson incoming President-Elect of the American Diabetes Association and President and Scientific Director of the Pacific Northwest Research Institute (PNRI) which is convening the Magnuson Congress for a Global Diabetes Alliance named for U.
Breaking new ground in biotechnology
Hindu – Aug 21, 2007
programme in Biotechnology. “The pharma industry and clinical research organisations in the country hesitate to recruit B. BT graduates as such candidates have little exposure to the practical aspects of BT or molecular biology. This is also true even of many B.
Science world riven by man on a mission to make research pay
Times nline – Aug 21, 2007
This has been done so that correct url isgenerated if we are coming from a section or topic –>Mark Henderson Science Editordiv#related-article-links p a div#related-article-links p a:visited {color:#06c;}A row has broken out within the government body that hands out more than £450million each year to medical research over its new chairman’s fitness forthe job. Sir John Chisholm who became chairman of the Medical Research Council lastyear has run into stiff opposition from scientists who fear that a US-stylebusiness-orientated agenda is taking clinical research in the wrongdirection. Sir John a former chief executive of the defence company QinetiQ wasappointed by the Government last year as it seeks to reshape medicalresearch. Ministers have placed a new emphasis on turning discoveries into therapiesthat can create wealth from health. While British science has always beengood at winning Nobel prizes it has been less successful at commercialisingdiscoveries such as those that underpin many modern cancer drugs.
Controlling AIDS lies in distant hope of vaccine
Seattle Post Intelligencer – Aug 21, 2007
“There’s no question we’ve made enormous strides in some areas” said Dr. Larry Corey director of the HIV Vaccine Trials Network and co-chairman of the meeting. The network headquartered at the Fred Hutchinson Cancer Research Center and operated in collaboration with the National Institutes of Health is the world’s largest AIDS vaccine clinical research program. It is testing 17 experimental vaccines in 28 cities including Seattle on five continents. At the Seattle meeting Corey noted researchers did hear some good news about two experimental HIV vaccines (one developed by Merck the other by the National Institutes of Health) that demonstrated enhanced cellular immunity as compared with earlier test vaccines. That approach causes the immune system to mount a response in which specialized cells such as T-cells attack the invaders. They have been shown for a time anyway to hold the virus at bay and perhaps delay progression to AIDS.
